Cognitive behaviour therapy is an effective strategy for overcoming the challenges of health anxiety
Patients with medically unexplained symptoms commonly present in primary care, accounting for up to a fifth of general practitioner consultations.1 Medically unexplained symptoms are defined as persistent and often debilitating symptoms for which a definitive medical cause cannot be identified after appropriate clinical examination and investigation.2 Due to the complex nature of their problems and a high use of health services, such patients represent a major challenge to the medical community.3 Understandably, in their quest to find an explanation and cure for their symptoms, they keep returning to their doctor in distress or crisis, sometimes with a diagnosis in mind, and other times frightened of having an unknown life-threatening medical condition that has gone undiagnosed. They often request referrals for specialist opinions, as well as repeated investigations that can increase the risk of false-positive results.4 Patients and doctors experience consultations as frustrating and difficult, and patients can be left feeling uncertain about how serious their symptoms might be, and lose trust in modern medicine.5
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Jackson JL, Passamonti M. The outcomes among patients presenting in primary care with a physical symptom at 5 years. J Gen Intern Med 2005; 20: 1032-1037.
- 2. van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev 2014; (11): CD011142.
- 3. Barsky AJ, Orav E, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903-910.
- 4. Lipsitt DR, Joseph R, Meyer D, Notman MT. Medically unexplained symptoms: barriers to effective treatment when nothing is the matter. Harv Rev Psychiatry 2015; 23: 438-448.
- 5. Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002; 32: 843-853.
- 6. Stone L. Blame, shame and hopelessness: medically unexplained symptoms and the ‘heartsink’ experience. Aust Fam Physician 2014; 43: 191-195.
- 7. Stone L. Managing medically unexplained illness in general practice. Aust Fam Physician 2015; 44: 624.
- 8. Olatunji BO, Kauffman BY, Meltzer S, et al. Cognitive-behavioral therapy for hypochondriasis/health anxiety: a meta-analysis of treatment outcome and moderators. Behav Res Ther 2014; 58: 65-74.
- 9. Sunderland M, Newby JM, Andrews G. Health anxiety in Australia: prevalence, comorbidity, disability and service use. Br J Psychiatry 2013; 202: 56-61.
- 10. Furer P, Walker JR, Stein MB. Treating health anxiety and fear of death: a practitioner’s guide. New York: Springer, 2007.
- 11. Seivewright H, Green J, Salkovskis P, et al. Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry 2008; 193: 332-337.
- 12. Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. Lancet 2013; 383: 219-225.
- 13. Hedman E, Andersson E, Lindefors N, et al. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychol Med 2013; 43: 363-374.
Jill Newby is supported by an Australian National Health and Medical Research Council Early Career Research Fellowship (grant 1037787).
No relevant disclosures.